Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population

Cancer Genetics and Cytogenetics

Volumn 195, Issue 1, 2009, Pages 43-53

  Rouissi, Kamel ^a   Ouerhani, Slah ^a   Oliveira, Elisabete ^b   Marrakchi, Raja ^a   Cherni, Lotfi ^a   Othman, Fethi Ben ^c   Ben Slama, Mohamed R ^c   Sfaxi, Mohamed ^c   Ayed, Mohsen ^c   Chebil, Mohamed ^c   Amorim, António ^b   Prata, Maria João ^b   Benammar Elgaaied, Amel ^a  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b UNIVERSITY OF PORTO   (Portugal)

^c CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); THYMIDYLATE SYNTHASE;

AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CARBON METABOLISM; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLATE METABOLISM; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; TUNISIA;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; AGED; CARBON; CASE-CONTROL STUDIES; FERREDOXIN-NADP REDUCTASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; THYMIDYLATE SYNTHASE; TUNISIA; URINARY BLADDER NEOPLASMS;

EID: 70349998625     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.06.007     Document Type: Article

References (38)

1. Silverman D.T., Rothman N., Devesa S.S., Syrigos K.N., and Skinner D.G. Bladder cancer: biology, diagnosis, and management (1999), Oxford University Press, New York 11-55
2. Parkin D.M., Whelan S., Ferlay J., Leppo L., and Thomas D.B. Cancer incidence in five continents (2002), France, IARC Publication, Lyon
3. Zeegers M.P., Tan F.E., Dorant E., and Van Den Brandt P.A. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89 (2000) 630-639
4. Mannino D.M., Mulinare J., Ford E.S., and Schwartz J. Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res 5 (2003) 357-362
5. Tungtrongchitr R., Pongpaew P., Soonthornruengyot M., Viroonudomphol D., Vudhivai N., Tungtrongchitr A., Phonrat B., Pooudong S., and Schelp F.P. Relationship of tobacco smoking with serum vitamin B-12, folic acid and haematological indices in healthy adults. Public Health Nutr 6 (2003) 675-681
6. Lwin H., Yokoyama T., Date C., Yoshiike N., Kokubo Y., and Tanaka H. Are the associations between life-style related factors and plasma total homocysteine concentration different according to polymorphism of 5,10-methylenetetrahydrofolate reductase gene (C677 T MTHFR)? A cross-sectional study in a Japanese rural population. J Epidemiol 12 (2002) 126-5
7. Saw S.M., Yuan J.M., Ong C.N., Arakawa K., Lee H.P., Coetzee G.A., and Yu M.C. Genetic, dietary and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. Am J Clin Nutr 73 (2001) 232-239
8. Chen A.T.L., Reidy J.A., Annest J.L., Welty T.K., and Zhou H.G. Increased chromosome fragility as a consequence of blood folate levels, smoking status and coffee consumption. Environ Mol Mutagen 13 (1989) 319-4
9. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., Den Heijer M., Kluijtmans L.A., Van Den Heuvel L.P., and Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
10. Weisberg I., Tran P., Christensen B., Sibani S., and Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64 (1998) 169-172
11. van der Put N.M., Gabreëls F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., van den Heuvel L.P., and Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 62 (1998) 1044-1051
12. Harmon D.L., Shields D.C., Woodside J.V., McMaster D., Yarnell J.W., Young I.S., Peng K., Shane B., Evans A.E., and Whitehead A.S. Methionine synthase D919 G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 17 (1999) 298-309
13. Olteanu H., Munson T., and Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 41 (2002) 13378-13385
14. Mandola M.V., Stoehlmacher J., Muller-Weeks S., Cesarone G., Yu M.C., Lenz H.J., and Ladner R.D. A novel single nucleotide polymorphism within the 5′ tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity. Cancer Res 63 (2003) 2898-2904
15. Heijmans B.T., Boer J.M., Suchiman H.E., Cornelisse C.J., Westendorp R.G., Kromhout D., Feskens E.J., and Slagboom P.E. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res 63 (2003) 1249-1253
16. Moore L.E., Wiencke J.K., Bates M.N., Zheng S., Rey O.A., and Smith A.H. Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett 211 (2004) 199-207
17. Ouerhani S., Oliveira E., Marrakchi R., Ben Slama M.R., Sfaxi M., Ayed M., Chebil M., Amorim A., El Gaaied A.B., and Prata M.J. Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population. Cancer Genet Cytogenet 176 (2007) 48-53
18. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
19. Paz M.F., Avila S., Fraga M.F., Pollan M., Capella G., Peinado M.A., Sanchez-Cespedes M., Herman J.G., and Esteller M. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 62 (2002) 4519-4524
20. Oliveira E., Alves S., Quental S., Ferreira F., Norton L., Costa V., Amorim A., and Prata M.J. The MTHFR C677 T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J Pediatr Hematol Oncol 27 (2005) 425-429
21. Excoffier L., Laval G., and Schneider S. Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 1 (2005) 47-50
22. Mtiraoui N., Ezzidi I., Chaieb M., Marmouche H., Aouni Z., Chaieb A., Mahjoub T., Vaxillaire M., and Almawi W.Y. MTHFR C677 T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract 75 (2007) 99-106
23. Ameen G., Irani-Hakime N., Fawaz N.A., Mahjoub T., and Almawi W.Y. An Arab selective gradient in the distribution of factor VG1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677 T. J Thromb Haemost 3 (2005) 2126-2127
24. Lightfoot T.J., Skibola C.F., Willett E.V., Skibola D.R., Allan J.M., Coppede F., Adamson P.J., Morgan G.J., Roman E., and Smith M.T. Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev 14 (2005) 2999-3003
25. Niclot S., Pruvot Q., Besson C., Savoy D., Macintyre E., Salles G., Brousse N., Varet B., Landais P., Taupin P., Junien C., and Baudry-Bluteau D. Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphomas. Blood 108 (2006) 278-285
26. Skibola C.F., Forrest M.S., Coppedé F., Agana L., Hubbard A., Smith M.T., Bracci P.M., and Holly E.A. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104 (2004) 2155-2162
27. Lin J., Spitz M.R., Wang Y., Schabath M.B., Gorlov I.P., Hernandez L.M., Pillow P.C., Grossman H.B., and Wu X. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis 25 (2004) 1639-1647
28. Kimura F., Florl A.R., Steinhoff C., Golka K., Willers R., Seifert H.H., and Schulz W.A. Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder. Mutat Res 458 (2001) 49-54
29. Sanyal S., Festa F., Sakano S., Zhang Z., Steineck G., Norming U., Wijkström H., Larsson P., Kumar R., and Hemminki K. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25 (2004) 729-734
30. Karagas M.R., Park S., Nelson H.H., Andrew A.S., Mott L., Schned A., and Kelsey K.T. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study. Int J Hyg Environ Health 208 (2005) 321-327
31. Duthie S.J., Narayanan S., Brand G.M., Pirie L., and Grant G. Impact of folate deficiency on DNA stability. J Nutr 132 (2000) 2444S-2449S
32. Pogribny I.P., Muskhelishvili L., Miller B.J., and James S.J. Presence and consequence of uracil in preneoplastic DNA from folate/methyl-deficient rats. Carcinogenesis 18 (1997) 2071-2076
33. Leclerc D., Campeau E., Goyette P., Adjalla C.E., Christensen B., Ross M., Eydoux P., Rosenblatt D.S., Rozen R., and Gravel R.A. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 5 (1996) 1967-1974
34. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., and Ames B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 94 (1997) 3290-3295
35. Ballestar E., and Esteller M. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis 23 (2002) 1103-1109
36. Lenz H.J. Pharmacogenomics and colorectal cancer. Ann Oncol 15 Suppl. 4 (2004) 173-177
37. Kaneda S., Takeishi K., Ayusawa D., Shimizu K., Seno T., and Altman S. Role in translation of a triple tandemly repeated sequence in the 5′-untranslated region of human thymidylate synthase mRNA. Nucleic Acids Res 15 (1987) 1259-1270
38. Trinh B.N., Ong C.N., Coetzee G.A., Yu M.C., and Laird P.W. Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 111 (2002) 299-302